References
- Zhang L, Grennan-Jones F, Lane C, et al. Adipose tissue depot-specific differences in the regulation of hyaluronan production of relevance to Graves' orbitopathy. J Clin Endocrinol Metab 2012;97(2):653–662
- Hegedüs L, Bonnema SJ, Smith TJ, Brix TH. Treating the thyroid in the presence of Graves' ophthalmopathy. Best Pract Res Clin Endocrinol Metab 2012;26(3):313–324
- Wiersinga WM. Graves' orbitopathy: management of difficult cases. Ind J Endocrinol Metab 2012;16(Suppl 2):S150–S152
- Maheshwari R, Weis E. Thyroid associated orbitopathy. Ind J Ophthalmol 2012;60(2):87–93
- , European Group on Graves' Orbitopathy (EUGOGO)Mourits MP, Bijl H, Altea MA, et al. Outcome of orbital decompression for disfiguring proptosis in patients with Graves' orbitopathy using various surgical procedures. Br J Ophthalmol 2009;93(11):1518–1523
- Boboridis KG, Bunce C. Surgical orbital decompression for thyroid eye disease. Cochrane Database Syst Rev 2011;12:CD007630
- Mehta P, Durrani OM. Outcome of deep lateral wall rim-sparing orbital decompression in thyroid-associated orbitopathy: a new technique and results of a case series. Orbit 2011;30(6):265–268
- Prummel MF, Mourits MP, Berghout A, et al. Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy. New Engl J Med 1989;321:1353–1359
- Kahaly G, Schrezenmeir J, Krause U, et al. Cyclosporin and prednisone v. prednisone in treatment of Graves' ophthalmopathy: a controlled, randomized and prospective study. Euro J Clin Invest 1986;16:415–422
- Perros P, Weightman DR, Crombie AL, Kendall-Taylor P. Azathioprine in the treatment of thyroid-associated ophthalmopathy. Acta Endocrinol (Copenh) 1990;122(1):8–12
- Khanna D, Chong KK, Afifiyan NF, et al. Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy. Ophthalmology 2010;117(1):133–139
- Clarke LC, Fraser SG. Hospital Episode Statistics and trends in ophthalmic surgery 1998–2004. BMC Ophthalmol 2006;6:37
- Rajendram R, Lee RW, Potts MJ, et al. Protocol for the combined immunosuppression & radiotherapy in thyroid eye disease (CIRTED) trial: a multi-centre, double-masked, factorial randomised controlled trial. Trials 2008;9:6
- , European Group on Graves' Orbitopathy (EUGOGO)Wiersinga WM, Perros P, Kahaly GJ, et al. Clinical assessment of patients with Graves' orbitopathy: the EUGOGO recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol 2006;155(3):387–389
- Perros P, Wiersinga WM. The Amsterdam Declaration on Graves' orbitopathy. Thyroid 2010;20:245–246
- Estcourt S, Quinn AG, Vaidya B. Quality of life in thyroid eye disease: impact of quality of care. Eur J Endocrinol 2011;164(5):649–655